Monday, April 15, 2024
Advertisement
  1. You Are At:
  2. News
  3. India
  4. No major side-effects of HCQ found in Indian studies, usage to continue: ICMR

No major side-effects of HCQ found in Indian studies, usage to continue: ICMR

Even as the World Health Organisation (WHO) halted the hydroxychloroquine arm of its COVID-19 drug trials on Monday, the Indian Council of Medical Research (ICMR) today said that there were no major side-effects of the malaria drug in the studies in India.

India TV News Desk Edited by: India TV News Desk New Delhi Updated on: May 26, 2020 18:11 IST
FILE
Image Source : FILE

FILE

Even as the World Health Organisation (WHO) halted the hydroxychloroquine arm of its COVID-19 drug trials on Monday, the Indian Council of Medical Research (ICMR) today said that there were no major side-effects of the malaria drug found in the studies in India. It further gave a go-ahead on the usage of the drug under "strict medical supervision."

"A lot of drugs are being repurposed for COVID-19. Taking biological plausibility, in-vitro data, and safety of this drug (HCQ), we recommend it under strict medical supervision. Based on risk-benefit we found that possibly we should not deny our health workers from using it," the ICMR Director-General said at a media briefing today.

Earlier on Monday, WHO Director-General Dr. Tedros Adhanom Ghebreyesus had announced the suspension of trials saying that its experts need to review all available evidence to date. "The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board. The other arms of the trial are counting," Tedros had said at an online briefing. 

Advertisement

Read all the Breaking News Live on indiatvnews.com and Get Latest English News & Updates from India

Advertisement
Advertisement
Advertisement
Advertisement